| Jun 27 |
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
|
| Jun 25 |
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
|
| Jun 12 |
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
|
| May 22 |
QNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 Approvals
|
| May 9 |
Quoin Pharmaceuticals Non-GAAP EPS of -$1.11 misses by $0.70
|
| May 9 |
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
|
| May 2 |
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
|
